Clinical Trials Browser

Phase 1/2 × Interventional × Acetylcysteine × Clear all

NCT05123365 2026-03-10

An Optimal Dose Finding Study of N-Acetylcysteine in Patients With Myeloproliferative Neoplasms

Phase 1/2 Recruiting

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

NCT04291209 2023-09-06

Intratympanic N-Acetylcysteine for Prevention of Cisplatin-induced Ototoxicity.

Phase 1/2 Unknown

Deafness, Ear Diseases, Hearing Loss, Sensorineural, Hearing Loss

NCT03492047 2020-02-27

N-acetyl Cysteine Effect in Peripheral Neuropathy in Cancer Patients

Phase 1/2 Completed

Peripheral Nervous System Diseases